Petersen J. М., Carlson J. K., Dietrich G. et al. Multiple Francisella tuiarensis subspecies and с lades tularemia outbreak, Utah // Emerg. Infect. Dis. 2008 V. 14. № 12. P. 1928–1930.
Peterson A. T., Carroll D. S., Mills J. N. et al. Potential mammalian filovirus reservoirs // Emerg. Infecl Dis. 2004. V. 10. № 12. P. 2073–2081.
Petosa C., Collier P., Klimpel K. R. et al. Crystal structure of the anthrax toxin protective antigen // Nature. 1997. V 385, № 6619. P. 833–838.
Pfeffer М., Dobler G. R. Emergence of zoonotic arboviruses by animal trade and migration // Parasites & Vectors. 2010. V. 3. № 35 (http://www.parasitesandvectors.eom/content/3/l/35).
Pichla-Golton S. L., Lin S. W., Hensley S. E. et al. Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral ant.body in vivo // 1. Virol. 2009. V. 83. P. 5567–5573.
Pilo P., Perreten V., Frey J. Molecular epidemiology of Bacillus anthracis: determining the correct ongin // Appl. Environ. Microbiol. 2008 V 74. № 9 P. 2928–2931.
Piskurek O., Okada N. Poxviruses as possible vectors for horizontal transfer of retroposons from reptiles to mammals // Natl. Acad. Sci, USA. 2007. V. 104. № 29. P. 12046-12051.
Pitt J. I. Toxigenic fungi which are important? // Med. Mycol. 2000. V. 38 (Suppl. 1). P. 17–22.
PIuta K., Kacprzak M. M. Use of HIV as a gene transfer vector // Act. Biochim. Pol. 1009. V. 56. P. 531—595
Poli M. A., Rivera V. R., Hewetson J. F. et al. Detection of ricin by colorimetric and cnemiluminescence ELISA // Toxicon. 1994. V. 32. № 11. P. 1371–1377.
Pollitzer R. Plague stud.es. 4. Pathology // Bull. World Hlth Org. 1952. V. 5. P. 337–376.
Pomerantsev A. P., Staritsyn N. A. Behavior of heteroiogous recombinant plasmid pCET in cells of Bacillus anthracis // Genetika 1996. V. 32. № 4. P. 500–509.
Pomerantsev A. P., Sukovatova L. V., Marinin L. I. Characterization of a Rif-R population of Bacillus anthracL // Antibiot. Khimioter. 1993. V. 38. № 8–9. P. 34–38.
Portnoy D., Faikow S. Virulence-associated plasmids from Yersinia enterocolitica and Yersinia pest s // J. Bacteriol. 1981. V. 148. P. 877–883.
Powell A., Crozier J., Hodgson H. et al. A case of septicaemic anthrax in an intravenous drug user // В ViC Infectious Diseases, 2011 (http://www.biomedcentral com/1471-2334/11/21/).
Prabhu В. М., Ali S. F., Murdock R. C. et al. Copper nanoparticles exert size and concentration dependent toxicity on somatosensory neurons of rat // Nanotoxicol. 2010. V. 4. P. 150–160.
Pratt W. D., Gibbs P., Schmaljohn A. L. Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infect.ons of Venezuelan equine encephalitis virus in non-human primates // Vaccine. 1998. V. 16. № 9-10. P. 1056–1064.
Price E. E., Seymour M. L., Sarovich D. S. et al. Molecular epidemiologic investigation of an anthrax outbreak among heroin useis, Europe // Emerg. Infect. Dis. 2012. V. 18. № 8. P.1307–1313.
Promdonkoy B., Ellar D. J. Membrane pore architecture of a cytolytic toxin from Bacillus thuringiensis Biochem J. 2000. V 350. P. 275–282.
Pugh C. W., Tabatabai L. B., BrickerB. J. et al. Immunogenicity of Brucella-extracted and recombinant protein vaccines in CD-I and BALB/c mice // Am. J. Vet. Res. 1990. V. 51. P. 1413–1120.
Rajamohan F., Alzate O., Cotrill J. A. et al. Protein engineering of Bacillus thuringiensis delta-endotoxin: mutations at domain 11 of Сгу1лЬ enhance receptor affinity and toxicity toward gypsy moth larvae // Proc. Natl. Acad. Sci. USA. 1996. V. 93. P. 14338-14343.
Ramos V., Vasconcelos V. Palytoxin and analogs: biological and ecological effects // Mar. Drugs. 2010. V. 8. P. 2021–2037
Ramsay C. N, Stirling A., Smith J. et al. An outbreak of infection with Bacillus anthracis in injecting drug users in Scotland // Eurosurveillance. 2010 V. 15. Is. 2 (14января).
Raoult D. Treatment of Q Fever // Antimicrob. Agents and Chemother. 1993. V. 37. № 9. P. 1733–1736.
